Xaira Therapeutics

Biotech · South San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of life-changing medicines designed through the transformative power of artificial intelligence. Xaira Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $3.5 billion at its early-stage round in Aug 2025, the last priced event on record. It has raised $1.3 billion across 1 recorded round; the latest was a $1 billion Series A in Apr 2024.

PMV mark · valuation
$3.5B
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$1.3B
Last round
Series A
Apr 2024
How much has Xaira Therapeutics raised?
$1.3Bacross 1 recorded rounds · Apr 2024 – Apr 2024

Most recently, Xaira Therapeutics raised $1.0B in its Series A (Apr 2024).

Free account
More of Xaira Therapeutics with a free account
  • ·The complete investor list: 20 names
  • ·Watch Xaira Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Xaira Therapeutics round by round

1 rounds
Apr 2024Series A$1.0B▮

How much has Xaira Therapeutics raised?

Xaira Therapeutics has raised $1.3 billion in total; 1 of its rounds is on record. The largest on record was a $1 billion Series A in Apr 2024.

Xaira Therapeutics investors

20 investors are on record for Xaira Therapeutics, including Sequoia Capital, Lightspeed Venture Partners, SV Angel and New Enterprise Associates. By type, the record holds 12 venture capital firms and 1 family office.

For fundraisers
Raising for a company like Xaira Therapeutics?

20 investors have backed Xaira Therapeutics — start your target list with the firms already writing checks in biotech.

See all 20 investors →

Frequently asked about Xaira Therapeutics

How much has Xaira Therapeutics raised?
Xaira Therapeutics has raised $1.3B in total across 1 recorded funding rounds.
When was Xaira Therapeutics's last funding round?
Xaira Therapeutics's most recent recorded round was Series A in Apr 2024, raising $1.0B.